According to the World Health Organisation (WHO), over 350 million people globally suffer from arthritis, and despite ...

More than half the women in the treat-to-target group conceived within 3 months vs a median of 6.5 months for those in the ...

WASHINGTON -- Rheumatoid arthritis (RA) patients who achieved sustained remission had better long-term outcomes than those ...

Among participants in the landmark ORAL Surveillance study assigned to the JAK inhibitor tofacitinib (Xeljanz) and also using ...

SetPoint Medical, a clinical-stage healthcare company dedicated to people living with chronic autoimmune diseases, today ...

Many patients with rheumatic diseases refrain from telling their doctors about all physical and emotional symptoms they’re ...

Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration. Ann Rheum Dis. 2022 ...

Scientists have pinpointed a bacteria, often found in the mouth, which may trigger the painful joint condition.

Data demonstrate potential superiority of a targeted protein degradation strategy compared to kinase inhibition for both BTK and IRAK4 targets in sel ...

Substantial improvements in ultrasound technology and expanded use of it have necessitated an update of the 2012 ...